StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.20−0.15 (-42.59%)

Close on Nov 13, 2026Market cap $906.90KP/E –Yield –

Oragenics statistics

58 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$906.90K
$272.32M
Enterprise Value
-$1.32M
$146.23M
PB Ratio
0.83
2.00
P/TBV Ratio
0.83
2.22

Share statisticsIndustry

Shares Change (QoQ)
0.00%
0.50%
Float
4M
49M
Shares Held by Insiders
2.62%
11.7%
Shares Held by Institutions
1.50%
56.4%

Short sellingIndustry

Short Interest
835,778
–
Short Interest Change
-0.15%
-0.80%
Short % of Float
19.0%
9.01%
Short % of Shares Outstanding
18.5%
6.30%
Days to Cover
40.07
5.15

Stock price statisticsIndustry

52-Week High
$1.22
–
52-Week Low
$0.17
–
20-Day Moving Average
$0.37
–
50-Day Moving Average
$0.44
–
200-Day Moving Average
$0.58
–
Average True Range (14)
$0.04
–
Price Change (1 Week)
-42.4%
-1.15%
Price Change (1 Month)
-53.9%
-4.87%
Price Change (3 Months)
-62.4%
-21.0%
Price Change (6 Months)
-65.8%
-20.6%
Price Change (YTD)
-74.3%
-23.6%
Price Change (1 Year)
-82.7%
-22.4%
Price Change (3 Years)
-99.8%
-29.5%
Price Change (5 Years)
-100.0%
-77.9%
Price Change (10 Years)
-100.0%
-65.4%
Average Volume (10 Days)
5M
–
Average Volume (20 Days)
2M
–
Average Volume (90 Days)
573,474
–
Relative Volume
46.06
0.70
Relative Strength Index (14)
14.3
43.4
Volatility (1 Year)
78.7%
80.1%
Beta (5 Years)
1.31
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-176.1%
-49.9%
Return on Assets (ROA)
-120.3%
-40.6%

Financial positionIndustry

Interest Coverage
-547.81
-6.35

EfficiencyIndustry

Profits Per Employee
-$3.21M
-$689.41K
Employee Count
3
74
WACC
11.7%
10.2%

Income statement (TTM)Industry

Operating Income
-$9.94M
-$21.37M
Pretax Income
-$9.85M
-$12.95M
Net Income
-$9.62M
-$22.35M
EBITDA
-$9.94M
-$17.21M

Balance sheetIndustry

Net Cash (Debt)
$2.23M
$17.76M
Net Cash Per Share
$0.49
$0.80
Equity (Book Value)
$1.09M
$53.89M
Book Value Per Share
$0.24
$1.50
Tangible Book Value
$1.09M
$27.13M

Cash flow (TTM)Industry

Operating Cash Flow
-$9.26M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-1060.8%
-21.8%
Buyback Yield
-8.61%
-0.76%
Shareholder Yield
-8.61%
0.00%

Taxes and interestIndustry

Interest Expense
$18.15K
$2.90M

Scores and fair valueIndustry

Altman Z-Score
-109.56
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodOGENS&P 500DifferenceOGEN per yearS&P 500 per year
1 month-55.0%-3.0%−52.0 pts
3 months-62.1%-2.8%−59.3 pts
Year to date-74.3%+11.5%−85.8 pts
1 year-82.4%+13.5%−95.8 pts
3 years-99.8%+77.7%−177.5 pts-87.7%+21.1%
5 years-100.0%+72.6%−172.6 pts-82.2%+11.5%
10 years-100.0%+308.2%−408.2 pts-65.4%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M OGEN shares were sold short on Oct 30, 2026, down 0.1% from the previous report, or 19.02% of the shares available to trade. At recent volumes it would take 40.1 days to buy them back. Over the last 20 sessions, 36.6% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026835,778-0.1%20,85840.1
Oct 15, 2026836,995-0.6%22,79836.7
Sep 30, 2026841,634+4.4%33,81424.9
Sep 15, 2026806,542+1.5%21,81037.0
Aug 31, 2026794,915+0.8%52,60515.1
Aug 14, 2026788,923+1.0%20,17739.1
Jul 31, 2026781,094-0.3%24,98431.3
Jul 15, 2026783,091+1.0%27,31328.7
Jun 30, 2026775,021+3.0%46,03616.8
Jun 15, 2026752,810+6.2%57,79013.0
May 29, 2026708,926+8.0%42,39916.7
May 15, 2026656,580-4.0%55,74211.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?